DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS
DEAD

Serial Number

85525589

Owner

BRISTOL-MYERS SQUIBB COMPANY

Attorney

Marilyn F. Kelly

Filing Date

Jan 26, 2012

Add to watchlist:

No watchlists yet
View on USPTO

DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS Trademark

Serial Number: 85525589

DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS is a trademark filed by BRISTOL-MYERS SQUIBB COMPANY on January 26, 2012. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

BRISTOL-MYERS SQUIBB COMPANY (4,814 trademarks)

NEW YORK, NY 10154

Entity Type: 03

Trademark Details

Filing Date

January 26, 2012

Registration Date

Not Registered

Goods & Services

Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 14, 2012 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 14, 2012 ABN2
ASSIGNED TO EXAMINER
Jul 10, 2012 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 18, 2012 GNRN
NON-FINAL ACTION E-MAILED
May 18, 2012 GNRT
NON-FINAL ACTION WRITTEN
May 18, 2012 CNRT
ASSIGNED TO EXAMINER
May 5, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 30, 2012 NWOS
NEW APPLICATION ENTERED
Jan 30, 2012 NWAP